HOME >> MEDICINE >> NEWS
Combining osteoporosis treatments does not produce better results

Combining two currently available types of osteoporosis drugs does not improve bone density, according to a study by researchers at Massachusetts General Hospital (MGH). Their report, appearing in the September 25 New England Journal of Medicine, describes how men with osteoporosis who received both alendronate and parathyroid hormone (PTH) actually had lower bone density at the end of the almost three-year study than did men receiving PTH alone. The journal is releasing this study and related articles early to coincide with presentations being made at the American Society for Bone and Mineral Research meeting in Minneapolis.

Maintaining healthy bone density requires a balance between two natural processes, the breakdown or resorption of old bone and the formation of new bone. When this balance shifts toward breakdown, bones become less dense and more prone to fracture. Although this condition, called osteoporosis, is seen most frequently in postmenopausal women, it also occurs in men, sometimes as a result of medications that interfere with normal hormone production.

Alendronate, one of a type of drugs called bisphosphonates, is FDA approved to treat osteoporosis in men and women and works by slowing bone resorption. Injections of PTH, a treatment initially developed through MGH research, increase bone formation and were approved by the FDA in December 2002 to treat osteoporosis in men and women. Since the two medications work in complementary fashion to increase bone density, a treatment strategy combining both drugs appeared promising.

"While it seemed likely that combining these two medications would increase bone density more than giving either medication alone, animal studies investigating combination therapy gave conflicting results," says Joel Finkelstein, MD, the MGH endocrinologist who led the study. "Still, we did expect that the combination group would do best, so the actual outcome was a surprise."

The MGH resear
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
20-Sep-2003


Page: 1 2 3

Related medicine news :

1. Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients
2. Combining hormones with external, internal radiation helps high risk prostate cancer patients
3. Combining liver transplantation and coronary artery bypass grafting can be safe and effective
4. Combining surgery with novel treatment may improve survival rates
5. Combining medication, family counseling improves treatment outcome for men who abuse heroin
6. Combining osteoporosis drugs produce no added benefit
7. Combining two types of radiation therapy better for treating brain cancer
8. Study Finds Combining Exercise With Male Hormone Therapy Benefits Men With HIV-Wasting Disease
9. History of broken bones overlooked when treating osteoporosis
10. Screening for osteoporosis prevents hip fractures in older adults
11. Calcium boost to youths bones could reduce osteoporosis risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology:
Cached News: